HACKENSACK, N.J., Feb. 27 /PRNewswire-FirstCall/ -- DOV Pharmaceutical, Inc. announced today that Dr. Leslie Hudson, President and CEO, will present at the Citigroup Global Healthcare Conference on Tuesday, Feb. 28, 2006. Dr. Hudson's presentation is scheduled to begin at 1:20 p.m. at the Mayflower Hotel in Washington, D.C. Dr. Hudson will discuss the development and commercialization strategy for DOV's leading product candidates and data from the Company's late stage clinical development programs.
A Web cast of the presentation may be accessed through the DOV Pharmaceutical Web site at http://www.dovpharm.com and Dr. Hudson's presentation will be archived and available on the Investor Relations section of DOV's Web site after the conference for 90 days.
About DOV
DOV is a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system disorders which involve alterations in neuronal processing. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, pain and depression. Our partner Neurocrine has filed two NDAs for the use of DOV's compound indiplon for the treatment of insomnia.
DOV Pharmaceutical, Inc.CONTACT: Keri P. Mattox, Director, Investor Relations and CorporateCommunications, of DOV Pharmaceutical, Inc., +1-201-968-0980
Web site: http://www.dovpharm.com/
